Your browser doesn't support javascript.
loading
Targeting Lysine-Specific Demethylase 1 Rescues Major Histocompatibility Complex Class I Antigen Presentation and Overcomes Programmed Death-Ligand 1 Blockade Resistance in SCLC.
Nguyen, Evelyn M; Taniguchi, Hirokazu; Chan, Joseph M; Zhan, Yingqian A; Chen, Xiaoping; Qiu, Juan; de Stanchina, Elisa; Allaj, Viola; Shah, Nisargbhai S; Uddin, Fathema; Manoj, Parvathy; Liu, Michael; Cai, Sheng F; Levine, Ross; Quintanal-Villalonga, Álvaro; Sen, Triparna; Chow, Andrew; Rudin, Charles M.
  • Nguyen EM; Cancer Biology Program, Louis V. Gerstner Jr. Graduate School of Biomedical Sciences, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Taniguchi H; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Chan JM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Zhan YA; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Chen X; Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Qiu J; Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, New York.
  • de Stanchina E; Antitumor Assessment Core, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Allaj V; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Shah NS; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Uddin F; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Manoj P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Liu M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Cai SF; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Levine R; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, New York; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Quintanal-Villalonga Á; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Sen T; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Chow A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Rudin CM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, New York; Graduate Program in Pharmacology, Weill Cornell Medical College, New York, New York. Electronic address: rudinc@mskcc.org.
J Thorac Oncol ; 17(8): 1014-1031, 2022 08.
Article en En | MEDLINE | ID: mdl-35691495
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígenos de Histocompatibilidad Clase I / Presentación de Antígeno / Carcinoma Pulmonar de Células Pequeñas / Histona Demetilasas / Neoplasias Pulmonares Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígenos de Histocompatibilidad Clase I / Presentación de Antígeno / Carcinoma Pulmonar de Células Pequeñas / Histona Demetilasas / Neoplasias Pulmonares Límite: Animals / Humans Idioma: En Año: 2022 Tipo del documento: Article